Nichiban Co., Ltd. develops, manufactures, and sells medical products and tapes in Asia and Europe. It offers medical products, including surgical tapes, wound care dressing tapes, post-operative care tapes, cornea protection tapes, and hemostatic and first-aid bandages; and sports tapes, underwraps, scissors, and bags. The company also provides curative drug for corns, calluses, and warts; Navel Compression pack, which is used for umbilical hernia compression treatment in infants; and fabric plasters, permeable film and puncture site protection dressings, absorbent hemostatic pressure dressings, and non-woven surgical tapes. In addition, it offers industrial tapes for use in packaging, carton boxes, agriculture, vehicles, construction, home appliances and electronic materials, and machinery applications, as well as adhesive tapes; and anti-inflammatory patches, foot care products, and waterproof films. Further, the company provides taping tapes, kinesiology tapes, bandages, plasters, pain relief creams, and bandages; and stationery and office products comprising cellulose adhesive tapes, double sided tapes, adhesive transfer tapes, book binding tapes, and others. The company was founded in 1918 and is headquartered in Tokyo, Japan.
Stock data | 2024 | Change |
---|---|---|
Price | $13.62 | N/A |
Market Cap | $277.19M | N/A |
Shares Outstanding | 20.35M | N/A |
Employees | 1.27K | N/A |